Trade Summary

Yesterday, Quinlan Paul T, serving as General Counsel at Oruka Therapeutics, Inc. (ORKA), sold 733 shares at $69.69 per share, for a total transaction value of $51,082.77. Following this transaction, Quinlan Paul T now holds 31,034 shares of ORKA.

This sale represents a 2.31% decrease in Quinlan Paul T's stake in the company. This is considered a medium-conviction trade.

The trade was executed on Monday, June 15, 2026 and publicly disclosed via SEC Form 4 filing on Monday, June 15, 2026 at 6:50 PM ET, meaning the disclosure happened on the same day as the trade.

Oruka Therapeutics, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.